ES2115003T3 - Aminocicloalcanobenzodioxoles como agentes adrenergicos selectivos beta-3. - Google Patents

Aminocicloalcanobenzodioxoles como agentes adrenergicos selectivos beta-3.

Info

Publication number
ES2115003T3
ES2115003T3 ES93121091T ES93121091T ES2115003T3 ES 2115003 T3 ES2115003 T3 ES 2115003T3 ES 93121091 T ES93121091 T ES 93121091T ES 93121091 T ES93121091 T ES 93121091T ES 2115003 T3 ES2115003 T3 ES 2115003T3
Authority
ES
Spain
Prior art keywords
aminocicloalcanobenzodioxoles
adrenergic agents
selective adrenergic
agents beta
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93121091T
Other languages
English (en)
Inventor
Joseph William Epstein
Gary Harold Birnberg
Gary Edward Walker
Minu Dhanjisha Dutia
Jonathan David Bloom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ES2115003T3 publication Critical patent/ES2115003T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings

Abstract

LA INVENCION ES AGONISTA DE ANTIOBESIDAD/ANTIDIABETES/BETA-3 DE FORMULA (FORMULA) EN DONDE LOS SUSTITUYENTES R0, R1, R4, R4'', R5, R6 O N SON COMO SE DEFINEN EN LA ESPECIFICACION.
ES93121091T 1993-01-29 1993-12-30 Aminocicloalcanobenzodioxoles como agentes adrenergicos selectivos beta-3. Expired - Lifetime ES2115003T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1097393A 1993-01-29 1993-01-29

Publications (1)

Publication Number Publication Date
ES2115003T3 true ES2115003T3 (es) 1998-06-16

Family

ID=21748304

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93121091T Expired - Lifetime ES2115003T3 (es) 1993-01-29 1993-12-30 Aminocicloalcanobenzodioxoles como agentes adrenergicos selectivos beta-3.

Country Status (10)

Country Link
US (2) US5510376A (es)
EP (1) EP0608568B1 (es)
JP (1) JPH072831A (es)
KR (1) KR940018376A (es)
AT (1) ATE163930T1 (es)
CA (1) CA2114359A1 (es)
DE (1) DE69317399T2 (es)
DK (1) DK0608568T3 (es)
ES (1) ES2115003T3 (es)
SG (1) SG47557A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
EP0825189B1 (en) * 1995-05-12 2002-01-02 Nisshin Pharma Inc. 1,4-benzodioxin derivatives
EP0801060A1 (en) * 1996-04-09 1997-10-15 Pfizer Inc. Heterocyclic Beta-3 Adrenergenic Agonists
EP1070046A1 (en) 1998-04-06 2001-01-24 Fujisawa Pharmaceutical Co., Ltd. Propanolamine derivatives
WO1999061055A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
GB9913083D0 (en) * 1999-06-04 1999-08-04 Novartis Ag Organic compounds
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
DE10142722A1 (de) * 2001-08-31 2003-03-27 Aventis Pharma Gmbh C2-substituierte Indan-1-one und ihre Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
MX2009002893A (es) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
JP5535931B2 (ja) 2008-10-27 2014-07-02 武田薬品工業株式会社 二環性化合物
TR201908314T4 (tr) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
IL295075A (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79323A (en) * 1985-07-10 1990-03-19 Sanofi Sa Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them
US5061727A (en) * 1990-05-04 1991-10-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles

Also Published As

Publication number Publication date
DK0608568T3 (da) 1998-09-28
JPH072831A (ja) 1995-01-06
EP0608568B1 (en) 1998-03-11
CA2114359A1 (en) 1994-07-30
US5594027A (en) 1997-01-14
DE69317399T2 (de) 1998-07-02
SG47557A1 (en) 1998-04-17
DE69317399D1 (de) 1998-04-16
US5510376A (en) 1996-04-23
KR940018376A (ko) 1994-08-16
EP0608568A1 (en) 1994-08-03
ATE163930T1 (de) 1998-03-15

Similar Documents

Publication Publication Date Title
FI931708A0 (fi) Herbicida substituerade aryl-haloalkylpyrazoler
ES2115003T3 (es) Aminocicloalcanobenzodioxoles como agentes adrenergicos selectivos beta-3.
DK0486948T3 (da) Forbindelser, der hæmmer retrovirale proteaser
DE69319976T2 (de) 7-Substituierte-9-substituierte Glycylamido-6-Demethyl-6-Deoxytetracycline
ATE334961T1 (de) Herbizide
PT618190E (pt) 9-¬glicil substituido)amido|-6-(substituido)-5-hidroxi-6-desoxitetraciclinas
DK0707007T3 (da) Amino(thio)etherderivater som CNS-aktive midler
ES2176776T3 (es) Ligandos del neuropeptido-y.
ES2136887T3 (es) Derivados antifungicos de sordaridina.
ES2166046T3 (es) Derivados de arilacrilamida como agonistas o antagonistas de 5ht1.
PT882726E (pt) Carbazol-carboxamidas como agonistas 5-ht1f
ES2094136T3 (es) Intermediarios quirales de 1,5-diyodo-2-metoxi o benciloxi.
DK719388A (da) Propoxybenzenderivater og fremgangsmaade til fremstilling deraf
EA200000016A1 (ru) Гидроксициклопентанон
DK0841327T3 (da) Triazolantisvampemiddel
ES8403108A1 (es) Un procedimiento para preparar azetidinas.
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
ATE190334T1 (de) Azlacton-derivatisierte polyamide
ATE72445T1 (de) 4'-epi-4'-aminoanthracycline.
DK0412538T3 (da) Bladglansmiddel
DK0381114T3 (da) Exo-3,4-O-benzyliden-3"-demethylchartreusin og salte deraf
ES2017493B3 (es) Herbicidas de difenil-eter.
MA21366A1 (fr) Herbicides a base de diphenylether.
ES2053808T3 (es) Nuevos compuestos azolicos.
PT1140932E (pt) Derivados de 1,8-benzonaftiridina

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 608568

Country of ref document: ES